Fear of Recurrence and Stopping Immunotherapy

Recruiting now · Not applicable

Conditions studied: Cognitive Behavioral Therapy

In brief

The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.

Key facts

Study ID

NCT04761328

Run by

University of Pittsburgh

People needed

100

Starts

2021-08-02

Expected to finish

2028-12-31

Last updated by the study team

2025-12-05

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 21 years and older
• Fluent in English
• Diagnosis of cancer and history of treatment with immunotherapy

You may not qualify if…

• Active suicidal ideation, delusions or hallucinations

Where it is running

• UPMC Hillman Cancer Centers — Pittsburgh, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.